Specialty drug prior auth is destroying your access timeline. Here's the playbook.
Specialty drug PA cycles average 7-21 days manually. Patient access delays at that scale damage clinical outcomes + patient satisfaction. AI-supported PA compresses cycles to 1-3 days. This page covers the playbook.
Why specialty drug PA is uniquely painful
Each drug has payer-specific clinical criteria, often tied to NCCN or other guidelines. PA submission requires clinical documentation matching payer criteria precisely. Manual preparation takes 30-90 minutes per PA. Denials require appeal with clinical narrative.
AI-supported PA workflow
Read the order from EHR. Identify payer + drug + clinical criteria. Extract documentation supporting criteria. Package + submit. Track to determination. Compresses 30-90 minute manual process to 5-10 minutes assisted.
Patient assistance program coordination
Specialty drugs carry significant patient cost-share. Manufacturer patient assistance programs + copay cards + foundation grants reduce barriers. Integrate PAP coordination with PA submission for end-to-end access workflow.
Appeal strategy for specialty drug denials
NCCN guideline alignment is the most powerful appeal argument. FDA-approved indication + clinical evidence + treatment guideline citation. Successful specialty drug appeals can overturn 50-70 percent of initial denials.
Specialty pharmacy coordination
Specialty drugs often dispense through specialty pharmacy networks. Authorization timing + dispensing timing + administration timing all need coordination. AI-supported workflow keeps the cycle in sync.
Free specialty drug PA audit
Send us your specialty drug PA volume + average cycle time + denial rate. We return diagnostic with cycle time analysis + workflow improvement plan + AI ROI estimate.
Don't wait. Get a senior partner on this.
ASP-RCM senior partners do same-day consultations on operational distress situations. 30 minutes. No SDR triage. Diagnostic conversation. You leave with a plan whether or not you engage us further.